Verge Fund

Verge HealthTech Fund builds a global investment portfolio by identifying and backing early-stage health technology companies. It focuses on transformative technologies designed to enhance healthcare accessibility, improve quality, and increase efficiency. The fund’s investment thesis spans various healthtech sectors, including AI and data analytics, next-gen diagnostics, smart devices, digital health platforms, digital therapeutics, and healthcare SaaS solutions.

The firm was founded in 2018 by Dr. Joseph Mocanu and Ed Deng. Their collaboration stemmed from a shared insight into the capital gap within the healthtech landscape and a conviction that technology could significantly address the inefficiencies of traditional healthcare systems. Both founders bring a strong pedigree as experienced healthtech operators, leveraging their backgrounds to actively partner with the ventures they support.

Verge HealthTech Fund seeks to support visionary and passionate founders who are shaping the future of healthcare. It serves as an active partner to these early-stage healthtech startups, offering expertise and access to a global network. The company’s overarching vision is to foster innovation that scales, ultimately impacting millions of lives worldwide by making healthcare exponentially more effective and accessible for all.